Endpoint definition
↥| Name | ASTHMA_ALLERG |
|---|---|
| Long name | Asthma and allergy |
| Conditions required | ALLERG_ASTHMA |
| Include | L12_ATOPIC, ALLERG_RHINITIS, H7_ALLERGICCONJUNCTIVITIS, FOOD_ALLERGY, Z21_DESEN_ALLERGE, POLLENALLERG |
| First defined in version | DF2 |
Asthma and allergy
allergic rhinitis: Inflammation of the nasal mucous membranes caused by an IgE-mediated response to external allergens. The inflammation may also involve the mucous membranes of the sinuses, eyes, middle ear, and pharynx. Symptoms include sneezing, nasal congestion, rhinorrhea, and itching. It may lead to fatigue, drowsiness, and malaise thus causing impairment of the quality of life.
Summary Statistics
↥Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 2215 | 1539 | 676 |
| Unadjusted prevalence (%) | 1.02 | 1.25 | 0.72 |
| Mean age at first event (years) | 27.72 | 28.68 | 25.52 |
| Case fatality at 5-years (%) | 0.00 | 0.00 | 0.00 |
Longitudinal metrics
| All | Female | Male | |
|---|---|---|---|
| Median nb. of events per indiv. | 2.0 | 2.0 | 1.0 |
| Recurrence at 6 months (%) | 29.69 | 31.10 | 26.21 |
Survival analyses between endpoints
↥Plot
before Asthma and allergy
after Asthma and allergy
Loading survival analyses plot…
Table
Loading survival analyses table…